Archimica S.p.A is an Italian-based company founded in 2006, specializing in the manufacturing and pharmaceutical industries. The company's slogan, "APIs, Building Blocks, CDMO, Process Development and Manufacturing for the Innovative and Generic Pharmaceutical Industry," reflects its focus on providing quality products and services for the pharmaceutical sector. Archimica S.p.A offers its own products (APIs) for the generic pharmaceutical industry, positioning itself as a key player in the market. The company prides itself on consistently delivering high-quality products and services, utilizing some of the world’s most difficult to handle chemical technologies. Archimica S.p.A's offerings include a wide range of services and products, including synthesis, manufacturing services, and regulatory starting materials for all global markets, including the United States of America. The company's products are available in 25 countries, demonstrating its global reach and impact. Although specific details about the latest investment and investors are not available, it is evident that Archimica S.p.A's independent one-site, single-entity corporate setup and highly differentiated technologies position it as an attractive investment opportunity. With its strong focus on the pharmaceutical industry and global expansion, Archimica S.p.A presents itself as a promising player in the market, offering lucrative investment potential for venture capitalists seeking opportunities in the manufacturing and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for Archimica S.p.A.